Our Pledge to Patients

Our Pledge to Patients

Marinus is committed to developing breakthrough therapies to improve the quality of lives of patients and their families as they battle rare and life-threatening diseases.

We strive to offer peace of mind to families by making available treatment options that will be convenient, fast acting, well-tolerated, and safe. Our passionate and dedicated team of professionals is working relentlessly to make a positive difference in these patients’ lives.


Find helpful patient resources and clinical trial information that we’ve compiled below.

CDKL5 Deficiency Disorder (CDD)

 

PCDH19 Pediatric Epilepsy

 

Postpartum Depression (PPD)

 

Status Epilepticus (SE)

 

Collaboration

We collaborate with patient advocacy organizations to increase awareness and education, to enable earlier diagnosis, to advance new therapies, and to better understand the patients we serve. Together, we hope to make a difference in many lives.

If you are a patient advocacy organization and interested in collaborating with us, please send an email to lcaperelli@marinuspharma.com.

Our Guiding Principles

At Marinus, integrity and trust are of the utmost importance. That is why we abide by BIO patient engagement principles as we work with patient advocacy organizations to better support the patients we serve, and to help raise awareness and understanding of the unmet needs we work to address. You can learn more about these principles here.

Our Guiding Principles

Compassionate Use Policy

We take our responsibility to act as a true partner with the medical community very seriously and are committed to ensuring our innovations reach as many patients as possible, as quickly as possible.

To request a copy of the company’s compassionate use policy, please click here.